BioNTech
BNTX
BNTX
250 hedge funds and large institutions have $4.95B invested in BioNTech in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 67 increasing their positions, 88 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
24% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 88
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
29% less call options, than puts
Call options by funds: $113M | Put options by funds: $159M
Holders
250
Holding in Top 10
3
Calls
$113M
Puts
$159M
Top Buyers
| 1 | +$273M | |
| 2 | +$122M | |
| 3 | +$43.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$38.1M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$34.4M |
Top Sellers
| 1 | -$267M | |
| 2 | -$197M | |
| 3 | -$59.9M | |
| 4 |
BlackRock
New York
|
-$54.1M |
| 5 |
Bank of New York Mellon
New York
|
-$53.3M |
